211 related articles for article (PubMed ID: 22517775)
21. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
[TBL] [Abstract][Full Text] [Related]
22. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
[TBL] [Abstract][Full Text] [Related]
23. Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.
Gourcerol G; Wu SV; Yuan PQ; Pham H; Miampamba M; Larauche M; Sanders P; Amano T; Mulak A; Im E; Pothoulakis C; Rivier J; Taché Y; Million M
Gastroenterology; 2011 May; 140(5):1586-96.e6. PubMed ID: 21277852
[TBL] [Abstract][Full Text] [Related]
24. Peripheral corticotropin-releasing factor (CRF) induces stimulation of gastric contractions in freely moving conscious rats: role of CRF receptor types 1 and 2.
Nozu T; Tsuchiya Y; Kumei S; Takakusaki K; Okumura T
Neurogastroenterol Motil; 2013 Feb; 25(2):190-7. PubMed ID: 23205497
[TBL] [Abstract][Full Text] [Related]
25. Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon.
Liu S; Ren W; Qu MH; Bishop GA; Wang GD; Wang XY; Xia Y; Wood JD
Br J Pharmacol; 2010 Jan; 159(1):222-36. PubMed ID: 20002096
[TBL] [Abstract][Full Text] [Related]
26. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.
Yakabi K; Noguchi M; Ohno S; Ro S; Onouchi T; Ochiai M; Takabayashi H; Takayama K; Harada Y; Sadakane C; Hattori T
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E72-82. PubMed ID: 21540451
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.
Wu SV; Yuan PQ; Wang L; Peng YL; Chen CY; Taché Y
Endocrinology; 2007 Apr; 148(4):1675-87. PubMed ID: 17218420
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
Aubry JM; Turnbull AV; Pozzoli G; Rivier C; Vale W
Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723
[TBL] [Abstract][Full Text] [Related]
29. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
Martinez V; Barquist E; Rivier J; Taché Y
Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
[TBL] [Abstract][Full Text] [Related]
30. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications.
Wang L; Basa NR; Shaikh A; Luckey A; Heber D; St-Pierre DH; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G611-20. PubMed ID: 16959954
[TBL] [Abstract][Full Text] [Related]
31. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.
Larauche M; Gourcerol G; Wang L; Pambukchian K; Brunnhuber S; Adelson DW; Rivier J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G215-27. PubMed ID: 19407218
[TBL] [Abstract][Full Text] [Related]
32. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
Maillot C; Million M; Wei JY; Gauthier A; Taché Y
Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
[TBL] [Abstract][Full Text] [Related]
33. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
Xu Y; Zhang R; Chen J; Zhang Q; Wang J; Hu J; Guan X; Jin L; Fu H; Gui B; Guo Y; Li S
Br J Pharmacol; 2009 Aug; 157(8):1368-79. PubMed ID: 19572944
[TBL] [Abstract][Full Text] [Related]
34. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis.
Chatzaki E; Lambropoulou M; Constantinidis TC; Papadopoulos N; Taché Y; Minopoulos G; Grigoriadis DE
J Cell Physiol; 2006 Dec; 209(3):905-11. PubMed ID: 16972272
[TBL] [Abstract][Full Text] [Related]
35. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts.
Lee S; Barbanel G; Rivier C
Brain Res; 1995 Dec; 705(1-2):136-48. PubMed ID: 8821744
[TBL] [Abstract][Full Text] [Related]
36. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.
Yuan PQ; Million M; Wu SV; Rivier J; Taché Y
Neurogastroenterol Motil; 2007 Nov; 19(11):923-36. PubMed ID: 17973638
[TBL] [Abstract][Full Text] [Related]
37. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors.
Rivier CL; Grigoriadis DE; Rivier JE
Endocrinology; 2003 Jun; 144(6):2396-403. PubMed ID: 12746300
[TBL] [Abstract][Full Text] [Related]
38. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
[TBL] [Abstract][Full Text] [Related]
39. Urocortin 1 inhibits rat leydig cell function.
Rivier CL
Endocrinology; 2008 Dec; 149(12):6425-32. PubMed ID: 18719027
[TBL] [Abstract][Full Text] [Related]
40. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
Uchida M; Suzuki M; Shimizu K
Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
